Jane Street Group, LLC V Tv Therapeutics Inc. Transaction History

Jane Street Group, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 17, 2022	SELL	$0.51 - $1.0 $7,115 - $13,951	-13,951 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$0.95 - $1.69 $13,253 - $23,577	13,951 New	13,951 $14,000
Q3 2021 Nov 16, 2021	SELL	$1.53 - $2.22 $112,132 - $162,701	-73,289 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.27 - $3.44 $166,366 - $252,114	73,289 New	73,289 $167,000
Q4 2020 Feb 17, 2021	SELL	$1.49 - $3.1 $23,546 - $48,989	-15,803 Closed	0 $0

Q3 2020 Nov 17, 2020	SELL	$1.7 - $2.98 $11,068 - $19,402	-6,511 Reduced 29.18%	15,803 $28,000
Q2 2020 Aug 17, 2020	BUY	$1.74 - $3.19 $38,826 - $71,181	22,314 New	22,314 $50,000
Q3 2018 Nov 14, 2018	SELL	$0.7 - $1.58 $17,404 - $39,283	-24,863 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$0.71 - $4.04 $17,652 - $100,446	24,863 New	24,863 $38,000

243K

Ticker VTVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,483,600
Market Cap $1.43B
Description
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetran...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.